Albert Einstein Hospital Israelita
São Paulo, 05652-900, Brazil
NCT Number: NCT07555444
The goal of this randomized clinical trial is to evaluate the efficacy of the Oral Care Kit, developed by Wecare, in reducing oral mucosal dryness and preventing oral ulcers in patients admitted to the ICU or step-down unit. The main questions it aims to answer are:
* Does the use of the Oral Care Kit reduce mouth dryness compared to standard treatment (artificial saliva)? * Does the use of the Oral Care Kit change salivary volume and flow compared to standard treatment (artificial saliva)? * Does the use of the Oral Care Kit alter the oral health condition of the participants?
Researchers will compare the use of the Oral Care Kit with artificial saliva care to see whether it reduces mouth dryness and improves patients' oral health.
Participants will:
* Use the Oral Care Kit or artificial saliva every 12 hours for 60 hours after their oral hygiene routine with daily toothbrushing with fluoridated toothpaste. * Have their mouth dryness, salivary flow rate, oral health conditions, and oral comfort assessed at Baseline and after 60 hours of intervention.
Looking for future studies?
Notify Me18 year–69 year
All sexes
Interventional
Not applicable
São Paulo, 05652-900, Brazil
Every 12 hours the participants will:
All participants:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Every 12 hours for 60 hours, participants follow a standardized oral hygiene routine: rinse with the Oral Care Kit mouthwash (5 or 10 mL) for 30 seconds, then apply a 2 g sachet of the oral gel, which is distributed across the entire oral mucosa and teeth. After application, participants are instructed to refrain from eating or drinking for 20 minutes and receive standardized oral care instructions from the Hospital Dentistry Team.
Every 12 hours for 60 hours, participants follow a standardized oral hygiene routine: they rinse with water (4 or 10 mL) for 30 seconds, then apply a 2 g sachet of artificial saliva, distributing it across the entire oral mucosa using the tongue. After application, participants are instructed to refrain from eating or drinking for 20 minutes and receive standardized oral care instructions from the Hospital Dentistry Team.
Time frame: Baseline and 60 hours post-intervention.
The degree of dryness of the oral mucosa is classified on a 0-4 scale, assessed visually under standardized lighting, with patients positioned supine and the bed inclined at 30-45°.
Time frame: Baseline and 60 hours post-intervention.
Unstimulated salivary volume (mL) is measured as the total saliva expectorated into a sterile tube over 3 minutes.
Time frame: Baseline and 60 hours post-intervention.
Salivary flow rate (mL/min) is calculated as the total unstimulated salivary volume collected over 3 minutes divided by the collection time.
Time frame: Baseline and 60 hours post-intervention.
An oral comfort questionnaire is used. Domains related to general psychological well-being and social aspects of oral health, typically included in instruments such as the Oral Health Impact Profile-14 (OHIP-14), were not included because participants were admitted to the intensive care unit (ICU) or step-down unit (SDU), where these factors are inherently influenced by clinical status. To reduce cognitive load, a five-point visual Likert scale with schematic facial expressions was used to represent increasing levels of positivity (1-5 points). To minimize participant burden, the questionnaire was kept brief and comprised six domains. Total scores range from 6 to 30, with higher scores indicating better oral comfort.
Time frame: Baseline and 60 hours post-intervention.
The participant's oral health condition is evaluated using the Bedside Oral Exam (BOE) scale, which comprises eight clinical criteria (swallowing, lips, tongue, saliva, mucous membranes, gums, teeth or dentures, and odor), each scored from 1 to 3. The total score ranges from 8 to 24 points, with 8 indicating good oral health and 24 representing severe dysfunction.
Hospital Israelita Albert Einstein
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03302676
Head and Neck Cancer, Head and Neck Neoplasms
Odense, Danmark, Denmark
View Trial DetailsNCT03578900
Arthritis, Arthritis, Rheumatoid
View Trial DetailsNCT00426543
Conjunctival Diseases, Conjunctivitis
Copenhagen, Denmark
View Trial DetailsNCT02049112
Arthritis, Arthritis, Rheumatoid
Magnanville, France
View Trial Details